✨ Free AI Report
Krystal Biotech, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Krystal Biotech, Inc.
Company Research

Krystal Biotech, Inc.: Business Overview, Financials & Competitive Analysis

Krystal Biotech, Inc. scores 8/10 on the AskCyborg Cyborg Score (Strong). Vyjuvek's commercial success and a robust catalyst-rich pipeline position Krystal for sustained growth. The company was upgraded to Strong Buy, driven by Vyjuvek's commercial success and a robust catalyst-rich pipeline. KRYS boasts 96% gross margins, nearly $1B in cash, and a platform poised to deliver multibillion dollar opportunities.

What is Krystal Biotech, Inc.'s industry? Krystal Biotech, Inc. (krystalbio.com) operates in Biotechnology / Gene Therapy / Rare Genetic Diseases. AskCyborg classifies Krystal Biotech, Inc. under Biotechnology / Gene Therapy / Rare Genetic Diseases in its company registry.

Krystal Biotech is a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases. The company commercializes VYJUVEK for the treatment of dystrophic epidermolysis ...

8/ 10Strong

Cyborg Score thesis

Vyjuvek's commercial success and a robust catalyst-rich pipeline position Krystal for sustained...

Read the full analyst-debate transcript →
Industry Biotechnology / Gene Therapy / Rare Genetic Diseases
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Krystal Biotech, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Krystal Biotech, Inc.

AskCyborg analysts argue the bull and bear cases for Krystal Biotech, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Krystal Biotech, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Krystal Biotech, Inc. Overview

Pro stress-test →

Krystal Biotech is a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases. The company commercializes VYJUVEK for the treatment of dystrophic epidermolysis bullosa (DEB).

Strategic Profile

Pro stress-test →

The company's wide-ranging pipeline is based on its proprietary redosable HSV vector. Vyjuvek delivered $97.8M revenue in Q3 2025 with 96% gross margin and a new at-home use label.

Competitive Landscape

Pro stress-test →

Key competitors in the gene therapy and rare disease space include Verve Therapeutics, Caribou Biosciences, Regenxbio, Abeona Therapeutics, and others. Krystal's proprietary redosable HSV vector platform and Vyjuvek's commercial success differentiate it in the rare genetic disease market.

Industry Context

Krystal Biotech, Inc. operates in Biotechnology / Gene Therapy / Rare Genetic Diseases.

Key facts

Founded: 2016 · Headquarters: Pittsburgh, Pennsylvania · Employees: 275 · Revenue: $373M · Market cap: $8.1B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Krystal Biotech, Inc..

  • Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to $107 million demonstrates strong commercial momentum.
  • FDA approved Krystal Biotech's label update for Vyjuvek allowing treatment of DEB patients from birth and enabling patient/caregiver application.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • January 20264Q 2025 Vyjuvek revenue guidance of $106-107 million announced
  • September 2025FDA approved Vyjuvek label update for at-home use and birth-onwards treatment
  • +1 moreTrack every material event for Krystal Biotech, Inc. as it happens. Explore monitoring →
Get alerted when Krystal Biotech, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Verve TherapeuticsGene therapy for cardiovascular disease→Caribou BiosciencesCell and gene therapy development→RegenxbioGene therapy platform company→Abeona TherapeuticsGene therapy for inherited disorders→

Compare Krystal Biotech, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Krystal Biotech, Inc. operates in Biotechnology / Gene Therapy / Rare Genetic Diseases. See how the rest of the sector scores on the Cyborg framework.

Top companies in Biotechnology by Cyborg Score

Browse Biotechnology / Gene Therapy / Rare Genetic Diseases research →
NEW · MCP server

Ask your AI assistant about Krystal Biotech, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Krystal Biotech, Inc. and its top competitor on Cyborg Score”
“What did Krystal Biotech, Inc. do this quarter?”
“Is Krystal Biotech, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Krystal Biotech, Inc. do?+
Krystal Biotech is a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases. The company commercializes VYJUVEK for the treatment of dystrophic epidermolysis ...
What is Krystal Biotech, Inc.'s Cyborg Score?+
Krystal Biotech, Inc. has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Krystal Biotech, Inc.'s main competitors?+
Named competitors include Verve Therapeutics, Caribou Biosciences, Regenxbio, Abeona Therapeutics. The full competitive landscape is in the AskCyborg report.
How can I get the full Krystal Biotech, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Krystal Biotech, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Krystal Biotech, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Biotechnology research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Abivax SA8Bavarian Nordic A/S8Beam Therapeutics Inc.8CG Oncology, Inc.8Cogent Biosciences, Inc.8COMPASS Pathways plc8CSL Limited8Eckert & Ziegler SE8Legend Biotech8Novonesis7REGENXBIO Inc.Top companies in Biotechnology by Cyborg Score